Sg Americas Securities, LLC Albireo Pharma, Inc. Transaction History

Sg Americas Securities, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	SELL	$16.32 - $26.37 $37,274 - $60,229	-2,284 Reduced 21.02%	8,583 $166,000
Q2 2022 Jul 29, 2022	BUY	$18.54 - $37.29 $201,474 - $405,230	10,867 New	10,867 $216,000
Q4 2021 Feb 07, 2022	SELL	$21.19 - $31.29 $155,513 - $229,637	-7,339 Closed	0 $0
Q3 2021 Nov 01, 2021	BUY	$27.36 - $35.98 $200,795 - $264,057	7,339 New	7,339 $229,000
Q2 2021 Aug 12, 2021	SELL	$28.9 - $36.87 $94,705 - $120,822	-3,277 Closed	0 $0

Q1 2021 May 13, 2021	BUY	$32.03 - $42.85 $104,962 - $140,419	3,277 New	3,277 $116,000
Q3 2020 Nov 09, 2020	SELL	$23.19 - $41.61 $167,733 - $300,965	-7,233 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$14.82 - $29.92 $107,193 - $216,411	7,233 New	7,233 $192,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.